Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity.
Fiche publication
Date publication
décembre 2017
Journal
Annals of intensive care
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MEUNIER-BEILLARD Nicolas
Tous les auteurs :
Andaluz-Ojeda D, Nguyen HB, Meunier-Beillard N, Cicuéndez R, Quenot JP, Calvo D, Dargent A, Zarca E, Andrés C, Nogales L, Eiros JM, Tamayo E, Gandía F, Bermejo-Martín JF, Charles PE
Lien Pubmed
Résumé
The use of novel sepsis biomarkers has increased in recent years. However, their prognostic value with respect to illness severity has not been explored. In this work, we examined the ability of mid-regional proadrenomedullin (MR-proADM) in predicting mortality in sepsis patients with different degrees of organ failure, compared to that of procalcitonin, C-reactive protein and lactate.
Mots clés
Biomarkers, MR-proADM, Mortality, SOFA, Sepsis
Référence
Ann Intensive Care. 2017 Dec;7(1):15